XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Family-oriented setup guidance to allocate every dollar and align spending with collective priorities.
19,524 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
In February 2026, a disciplined $1,000 starter plan can still unlock meaningful exposure to AI-driven growth. This re...
XRP remains range-bound after a volatile 2025, with traders eyeing regulatory clarity and macro trends as potential c...
Two big drivers could push Truist stock higher in 2026: cheaper funding and faster loan growth. This article breaks d...
Bitcoin is near a sensitive juncture as funding conditions tighten and equities remain richly valued. The coming week...
On Feb 26, The Trade Desk faced a sharp move as management guided softer revenue growth and rising margins strained b...
Europe is poised to become a leader in trusted, industrialized AI as regulators push for guardrails and firms invest ...
Two U.S. startups, Archer Aviation and Joby Aviation, are racing to pioneer urban air mobility. This guide breaks dow...
Bitcoin rose back toward the mid-60s, fueled by renewed risk appetite and easing inflation signals. This crypto price...
Gold climbs to new highs in March 2026 as a 2x gold ETF accelerates gains. With real yields sliding, leveraged exposu...
Oil jumps to its highest price since 2023 as a hot U.S. jobs report spurs inflation worries, sending stocks lower and...
RBC Capital Markets upgrades Dow Inc. and LyondellBasell to Outperform, citing Iran-related supply squeezes in global...